# Specimens for Septin 9 Performance

> **NCT01329718** · EARLY_PHASE1 · COMPLETED · sponsor: **Epigenomics, Inc** · enrollment: 562 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

- **OTHER:** Blood Sample

## Key facts

- **NCT ID:** NCT01329718
- **Lead sponsor:** Epigenomics, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 562 (ACTUAL)
- **Last updated:** 2014-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01329718

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01329718, "Specimens for Septin 9 Performance". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01329718. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*